Skip to main content
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
3.150
+0.250 (8.62%)
At close: Jun 6, 2025, 4:00 PM
3.170
+0.020 (0.63%)
After-hours: Jun 6, 2025, 7:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 2019 - 2020
Period Ending
 Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2019 - 2020
Other
563.00K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
86.42%
Log In
Log In
Log In
Log In
Upgrade
Product
30.66M
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 2018 - 2019
United States
Log In
Log In
Log In
Log In
Upgrade
United States Growth
Log In
Log In
Log In
Log In
Upgrade
Europe
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
Log In
Log In
Log In
Log In
Upgrade